Atlas Trials

Superficial Bladder Cancer

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Superficial Bladder Cancer

RecordFirmDate
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve (NCT04752722)enGene, Inc.2021-04-22
Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation (NCT05084586)Ankara Training and Research Hospital2019-10-01
Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer (NCT03379909)Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2019-09-01
A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) (NCT03121768)Mansoura University2017-05-15
ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) (NCT02773849)Ferring Pharmaceuticals2016-09-19
Therapeutic Instillation of Mistletoe (NCT02106572)Abnoba Gmbh2015-04-01
Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer (NCT01687244)FKD Therapies Oy2012-09-01
Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms (NCT01939756)Savino M. Di Stasi2012-01-01
Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer (NCT00782587)Halozyme Therapeutics2008-10-01
Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer (NCT00734994)Mark Dewhirst2008-04-01
Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer (NCT00595088)Anchiano Therapeutics Israel Ltd.2008-01-01
Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer (NCT00322699)North Florida/South Georgia Veterans Health System2005-02-01
Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer (NCT02007005)Abnoba Gmbh2004-01-01
A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer (NCT00192049)Eli Lilly and Company2003-12-01
Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer (NCT01149174)University of Rome Tor Vergata1994-01-01

Track Superficial Bladder Cancer automatically

Every clearance here is in the API, with alerts when new ones post.